SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Brady Angela) "

Sökning: WFRF:(Brady Angela)

  • Resultat 1-5 av 5
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Bancroft, Elizabeth K, et al. (författare)
  • Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study
  • 2014
  • Ingår i: European urology. - 1873-7560. ; 66:3, s. 489-499
  • Tidskriftsartikel (refereegranskat)abstract
    • Men with germline breast cancer 1, early onset (BRCA1) or breast cancer 2, early onset (BRCA2) gene mutations have a higher risk of developing prostate cancer (PCa) than noncarriers. IMPACT (Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in BRCA1/2 mutation carriers and controls) is an international consortium of 62 centres in 20 countries evaluating the use of targeted PCa screening in men with BRCA1/2 mutations.
  •  
2.
  • Blein, Sophie, et al. (författare)
  • An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.
  • 2015
  • Ingår i: Breast Cancer Research. - BioMed Central. - 1465-5411. ; 17:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Individuals carrying pathogenic mutations in BRCA1/2 genes have a high lifetime risk of breast cancer. BRCA1 and BRCA2 are involved in DNA double strand break repair, DNA alterations that can be caused by exposure to reactive oxygen species, a main source of which are mitochondria. Mitochondrial genome variations affect electron transport chain efficiency and reactive oxygen species production. Individuals from different mitochondrial haplogroups differ in their metabolism and sensitivity to oxidative stress. Variability in mitochondrial genetic background can alter reactive oxygen species production, leading to cancer risk. Here we test the hypothesis that mitochondrial haplogroups modify breast cancer risk in BRCA1/2 mutation carriers.
3.
  • Engel, Katja, et al. (författare)
  • Meeting Report 1st International Functional Metagenomics Workshop May 7-8, 2012, St. Jacobs, Ontario, Canada
  • 2013
  • Ingår i: Standards in Genomic Sciences. - 1944-3277. ; 8:1, s. 106-111
  • Tidskriftsartikel (övrigt vetenskapligt)abstract
    • This report summarizes the events of the 1st International Functional Metagenomics Workshop. The workshop was held on May 7 and 8, 2012, in St. Jacobs, Ontario, Canada and was focused on building an international functional metagenomics community, exploring strategic research areas, and identifying opportunities for future collaboration and funding. The workshop was initiated by researchers at the University of Waterloo with support from the Ontario Genomics Institute (OGI), Natural Sciences and Engineering Research Council of Canada (NSERC) and the University of Waterloo.
4.
  • Hoshino, Ayuko, et al. (författare)
  • Tumour exosome integrins determine organotropic metastasis
  • 2015
  • Ingår i: Nature. - NATURE PUBLISHING GROUP. - 0028-0836. ; 527:7578, s. 329-
  • Tidskriftsartikel (refereegranskat)abstract
    • Ever since Stephen Pagets 1889 hypothesis, metastatic organotropism has remained one of cancers greatest mysteries. Here we demonstrate that exosomes from mouse and human lung-, liver-and brain-tropic tumour cells fuse preferentially with resident cells at their predicted destination, namely lung fibroblasts and epithelial cells, liver Kupffer cells and brain endothelial cells. We show that tumour-derived exosomes uptaken by organ-specific cells prepare the pre-metastatic niche. Treatment with exosomes from lung-tropic models redirected the metastasis of bone-tropic tumour cells. Exosome proteomics revealed distinct integrin expression patterns, in which the exosomal integrins alpha(6)beta(4) and alpha(6)beta(1) were associated with lung metastasis, while exosomal integrin alpha(v)beta(5) was linked to liver metastasis. Targeting the integrins alpha(6)beta(4) and alpha(v)beta(5) decreased exosome uptake, as well as lung and liver metastasis, respectively. We demonstrate that exosome integrin uptake by resident cells activates Src phosphorylation and pro-inflammatory S100 gene expression. Finally, our clinical data indicate that exosomal integrins could be used to predict organ-specific metastasis.
  •  
5.
  • Peterlongo, Paolo, et al. (författare)
  • Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
  • 2015
  • Ingår i: Cancer Epidemiology, Biomarkers and Prevention. - American Association for Cancer Research. - 1055-9965. ; 24:1, s. 308-316
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: BRCA1 and BRCA2 mutation carriers are at substantially increased risk for developing breast and ovarian cancer. The incomplete penetrance coupled with the variable age at diagnosis in carriers of the same mutation suggests the existence of genetic and nongenetic modifying factors. In this study, we evaluated the putative role of variants in many candidate modifier genes. Methods: Genotyping data from 15,252 BRCA1 and 8,211 BRCA2 mutation carriers, for known variants (n = 3,248) located within or around 445 candidate genes, were available through the iCOGS custom-designed array. Breast and ovarian cancer association analysis was performed within a retrospective cohort approach. Results: The observed P values of association ranged between 0.005 and 1.000. None of the variants was significantly associated with breast or ovarian cancer risk in either BRCA1 or BRCA2 mutation carriers, after multiple testing adjustments. Conclusion: There is little evidence that any of the evaluated candidate variants act as modifiers of breast and/or ovarian cancer risk in BRCA1 or BRCA2 mutation carriers. Impact: Genome-wide association studies have been more successful at identifying genetic modifiers of BRCA1/2 penetrance than candidate gene studies.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-5 av 5
Åtkomst
fritt online (2)
Typ av publikation
tidskriftsartikel (5)
Typ av innehåll
refereegranskat (4)
övrigt vetenskapligt (1)
Författare/redaktör
Teixeira, Manuel R (3)
Eccles, Diana (3)
Izatt, Louise (3)
Lubinski, Jan (3)
Friedman, Eitan (3)
Aittomäki, Kristiina (2)
visa fler...
Nevanlinna, Heli (2)
Eeles, Rosalind A (2)
Cybulski, Cezary (2)
Neuhausen, Susan L (2)
Platte, Radka (2)
Evans, D. Gareth (2)
Buys, Saundra S. (2)
Spurdle, Amanda B. (2)
Benitez, Javier (2)
Schmutzler, Rita K. (2)
Meindl, Alfons (2)
Hamann, Ute (2)
Wang-Gohrke, Shan (2)
Andrulis, Irene L. (2)
Chenevix-Trench, Geo ... (2)
Easton, Douglas F. (2)
Thomassen, Mads (2)
Antoniou, Antonis C. (2)
McGuffog, Lesley (2)
Sinilnikova, Olga M. (2)
Healey, Sue (2)
Barrowdale, Daniel (2)
Frost, Debra (2)
Douglas, Fiona (2)
Stoppa-Lyonnet, Domi ... (2)
Mazoyer, Sylvie (2)
Rookus, Matti A. (2)
Jakubowska, Anna (2)
Gronwald, Jacek (2)
Goldgar, David E. (2)
Wappenschmidt, Barba ... (2)
Engel, Christoph (2)
Arnold, Norbert (2)
Niederacher, Dieter (2)
Sutter, Christian (2)
Domchek, Susan M. (2)
Nathanson, Katherine ... (2)
Piedmonte, Marion (2)
Laitman, Yael (2)
Glendon, Gord (2)
Gerdes, Anne-Marie (2)
Peterlongo, Paolo (2)
Manoukian, Siranoush (2)
Radice, Paolo (2)
visa färre...
Lärosäte
Karolinska Institutet (4)
Lunds universitet (3)
Uppsala universitet (2)
Linköpings universitet (2)
Umeå universitet (1)
Södertörns högskola (1)
Språk
Engelska (5)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (4)
Naturvetenskap (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy